Bruce C. Trapnell

Infection of A549 cells with a recombinant adenovirus vector induces ICAM-1 expression and increased CD-18-dependent adhesion of activated neutrophils.

J. Stark, B. Trapnell, R. Amin, 1996, Human gene therapy.

Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema.

B. Trapnell, Y. Shibata, N. Palaniyar, 2001, Blood.

An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.

Benjamin M. Smith, J. Moss, A. MacKenzie, 2017, Annals of the American Thoracic Society.

Molecular Pathogenesis of Alpha-1-antitrypsin Deficiency-associated Liver Disease: a Meeting Review in Recent Years, We Have Witnessed Several Important Paradigm Shifts in Understanding the Molecular Basis of Liver Disease in Alpha-1-antitrypsin (at) Deficiency. These Shifts Have Become Possible as

J. Brodsky, D. Perlmutter, W. Balistreri, 2022 .

Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy.

B. Trapnell, D. Kayda, M. Kaleko, 1998, Blood.

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.

B. Trapnell, D. Ennist, K. Harrod, 1998, Human gene therapy.

In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.

J. Whitsett, B. Trapnell, J. Whitsett, 1994, Human gene therapy.

Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector.

R. Wilmott, J. Stark, B. Trapnell, 1999, American journal of respiratory cell and molecular biology.